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Background: Neonatal sepsis contributes significantly to morbidity and mortality among young infants.
The aetiological agents as well as their susceptibility to antimicrobial agents are dynamic. This study determined
aetiology, antimicrobial susceptibility and clinical outcome of neonatal sepsis at Muhimbili National Hospital.
Methods: Three hundred and thirty neonates admitted at the Muhimbili National Hospital neonatal ward between
October, 2009 and January, 2010 were recruited. Standardized questionnaires were used to obtain demographic
and clinical information. Blood and pus samples were cultured on MacConkey, blood and chocolate agars and
bacteria were identified based on characteristic morphology, gram stain appearance and standard commercially
prepared biochemical tests. Antimicrobial sensitivity testing was performed for ampicillin, cloxacillin, gentamicin,
amikacin, cefuroxime and ceftriaxone on Mueller Hinton agar using the Kirby Bauer diffusion method.
Results: Culture proven sepsis was noted in 24% (74/330) of the study participants. Isolated bacterial pathogens
were predominantly Staphylococcus aureus, Klebsiella spp and Escherichia coli. Klebsiella spp 32.7% (17/52) was the
predominant blood culture isolate in neonates aged below seven days while Staphylococcus aureus 54.5% (12/22)
was commonest among those aged above seven days. Staphylococcus aureus was the predominant pus swabs
isolate for both neonates aged 0–6 days 42.2% (98/232) and 7–28 days 52.3% (34/65). Resistance of blood culture
isolates was high to ampicillin 81.1% (60/74) and cloxacillin 78.4% (58/74), moderate to ceftriaxone 14.9% (11/74)
and cefuroxime 18.9% (14/74), and low to amikacin 1.3% (1/74). Isolates from swabs had high resistance to
ampicillin 89.9% (267/297) and cloxacillin 85.2 (253/297), moderate resistance to ceftriaxone 38.0% (113/297) and
cefuroxime 36.0% (107/297), and low resistance to amikacin 4.7% (14/297). Sepsis was higher in neonates with
fever and hypothermia (p=0.02), skin pustules (p<0.001), umbilical pus discharge and abdominal wall hyperemia
(p=0.04). Presence of skin pustules was an independent predictor of sepsis OR 0.26, 95% CI (0.10-0.66) p=0.004.
The overall death rate was 13.9% (46/330), being higher in neonates with sepsis 24.3% (18/74) than those without
10.9% (28/256), p=0.003.
Conclusions: Staphylococcus aureus was predominant isolate followed by Klebsiella and Escherichia coli. There was
high resistance to ampicillin and cloxacillin. Mortality rate due to neonatal sepsis was high in our setting. Routine
antimicrobial surveillance should guide the choice of antibiotics for empirical treatment of neonatal sepsis.* Correspondence: fredrick.francis78@gmail.com
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Neonatal mortality contribute significantly to the infant
mortality rates in developing countries, various condi-
tions are responsible for neonatal mortality among
which is neonatal sepsis, which account for about 26%
of neonatal mortality [1]. About four million neonatal
deaths occur worldwide with reported highest rates in
Sub-Sahara Africa [1].
Neonatal sepsis which is defined as sepsis occurring in
the first 28 days of life can be divided into early onset
and late onset. Differentiation into early and late onset
neonatal sepsis is important in prevention and treatment
because of aetiological differences. Very few studies in
sub-Sahara Africa has looked into neonatal sepsis with
the focus on time of onset [2,3]. In this study we defined
early onset neonatal bacterial sepsis as sepsis in neonates
less than seven days and late onset as sepsis in 7 days
or more.
Clinical presentation of neonatal sepsis varies and
there are no pathognomonic features [4], however some
clinical features have been reported to predict sepsis.
Kayange et al. in a study which was conducted in
Bugando, Tanzania reported inability to breast feed, leth-
argy, convulsion, chest wall in-drawing, jaundice and
umbilical redness to be strongly associated with neonatal
sepsis [5]. Non-specific presentation of neonatal sepsis
and poor or delayed laboratory services have resulted in
empirical treatment of sepsis in resource limited set up.
In a study conducted in Kilimanjaro, Tanzania more
than two thirds of neonates admitted to a special care
baby unity received antibiotics [6].
In the management of neonatal sepsis, clinicians in
many resource limited settings make tentative diagnosis
and empirical treatment of neonatal sepsis based on
the new neonatal WHO Integrated Management of
Childhood Illnesses (n-IMCI) guidelines [7]. However
aetiology of neonatal sepsis as well as response to anti-
microbial agents may vary significantly from time to
time and geographically which may affect the success of
empirical management [5,7-10].
Currently at Muhimbili National Hospital, the largest
referral hospital in Tanzania, neonatal sepsis is managed
according to WHO guideline which recommends ampi-
cillin, cloxacillin and gentamycin as the first line antibio-
tics [11]. Reports of dynamic nature of the aetiological
agents and their response to antimicrobial agents in dif-
ferent geographical areas calls for availability of local
data in guiding choices of antibiotics. This study was
carried out to determine aetiology, antimicrobial resist-
ance of isolated bacteria and outcome of neonatal sepsis.
Methods
This was a hospital based cross-sectional study carried
out at Muhimbili National Hospital neonatal unit. Bothterm and preterm neonates admitted with clinical diag-
nosis of neonatal septicaemia, presenting with any one
of the following features were eligible; presence of fever
(≥ 38.0°C) or hypothermia (≤ 36.5°C), convulsions, leth-
argy, inability to feed, hypoglycaemia, vomiting, bulging
fontanels, respiratory distress, jaundice and signs of in-
fection on the skin (pus spots) and umbilical pus dis-
charge or hyperaemia. Sample size in this study was
calculated using Epi info version 6 statistical package,
and a prevalence of 16% from a study conducted previ-
ously at the same hospital by Bloomberg et al. [10] was
used with a target of recruiting about 300 participants.
During the study period 1811 were admitted in the neo-
natal ward out of which 330 fulfilled inclusion criteria
and were recruited.
Standardized questionnaires were used to obtain demo-
graphic and clinical information which included details of
thorough physical examination. Weight was measured
using SECA beam balance (CMS Weighing equipment,
London, United Kingdom) to the nearest 100g. Two milli-
litres of venous blood was aseptically drawn from anterior
cubital fossa of each neonate and inoculated into paediat-
ric blood culture bottles. Pus swab were taken from the
umbilical cord stump or skin pustules to determine the
contribution of cord stump/skin infection to sepsis and
correlate the two infections, pus swabs were transported
in Stuart transport media..
Blood culture bottles were incubated at 37°C for 24 h
after which aliquots were sub-cultured on solid agar
plates; MacConkey, blood and chocolate agars for up
96 h before being regarded as no growth. Pus swabs
were smeared on a glass slides for gram stain identifica-
tion and were also inoculated on solid MacConkey
agar at 37°C for 24 h. Colonies on solid agar plates were
identified based on characteristic morphology, gram
stain appearance and standard commercially prepared
biochemical tests [12].
Antimicrobial sensitivity testing was performed for
antimicrobials which included first and second line anti-
biotics for treating neonatal sepsis at MNH; first line
antibiotics are ampicillin, cloxacillin and gentamicin and
second line is ceftriaxone. Ampicillin 10μg, cloxacillin
5μg gentamicin 10μg, amikacin 30μg, cefuroxime 30μg,
and ceftriaxone 30μg sensitivity testing were performed
by Kirby Bauer diffusion method using Mueller Hinton
agar with incubation of 24 h at 37°C. Sensitivity was
determined according to Clinical Laboratory Standard
Institute standards [13]. Results were recorded as resist-
ant, intermediate and sensitive, however, during data
analysis intermediate were categorized as resistant.
Statistical Package for Social Sciences (SPSS) version
17 was used for data entering, cleaning and analysis. Chi
square and Fischer’s exact test were used to determine
association between categorical variables. Probability (p)
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This study was approved by MUHAS ethical committee
and informed written consents were obtained from
parents/guardian prior to recruitment. Results of labora-
tory tests were used in the participants’ management.
Results
Demographic and clinical characteristics of participants
Three hundred and thirty neonates with a median age of
3 days (range 0–26) were recruited. Hundred and sixty
(48.5%) were female and 253 (76.7%) were aged between
zero and six days. Table 1 shows demographic character-
istics of participants. Most frequently reported clinical
features of included pus discharge with hyperaemia
(96.1%) and fever (91.5%). Other included inability to
breastfeed, lower chest wall in-drawing, difficulty in
breathing, jaundice, bulging fontanelle, skin pustules,
convulsion and hypothermia (Table 1).
Bacterial isolation
Three hundred and two participants 91.5% (302/330)
had culture proven bacterial infection out of which




0 – 6 253 76.7





≤ 2500 109 33




Clinical features (signs & symptoms)
Fever 302 91.5
Hypothermia 8 2.4
Inability to feed 206 62.4
Bulging fontanelle 33 10.0
Difficulty in breathing 73 22.1
Lower chest wall in drawing 89 27.0
Convulsions 10 3.0
Umbilical pus discharge with hyperaemia 317 96.1
Skin rash with pus spots 31 9.4
Jaundice 44 13.3(5/330) had bacteria isolated from blood and 20.9% (69/
330) had bacteria isolated from both swabs and blood.
One hundred and ninety eight (66.7%) swabs were taken
from cord stump while 33.3% (99/297) were taken from
skin pustules. Among 69 participants who had bacteria
isolated from both swabs and blood 65.2% (45/69) had
the same bacteria isolated from both swabs and blood
and 34.8% (24/69) had different organisms isolated.
Therefore culture proven sepsis was present in 22.4%
(74/330).
Staphylococcus aureus was the most common isolated
organism from blood culture and pus swab, followed by
Klebsiella species and Escherichia coli. These three
organisms accounted for approximately 85% of all iso-
lates in blood culture and 94.3% of all isolates from pus
swab. For bacteria isolated from blood Klebsiella spp
32.7% (17/52) was predominant at the age 0 to 6 days
where as Staphylococcus aureus 54.5% (12/22) featured
more among neonates aged 7–28 days. (Table 2).
Staphylococcus aureus was the predominant isolate from
pus swabs in both 0–6 days 42.2% (98/323) and 7–28
days group 52.3% (34/65) (Table 3).
Antimicrobial susceptibility of isolated bacteria
Antimicrobial susceptibility pattern was performed for
all bacterial isolates. Isolates from both blood and pus
swabs had highest resistance against ampicillin and clox-
acillin. All Klebsiella spp isolates and 92.9% (13/14) of
Escherichia coli isolates from blood were resistant to ampi-
cillin, 77.0% (12/22) of Klebsiella spp and 42.9% (6/14) of
Escherichia coli isolated from blood were resistant to gen-
tamycin. Twenty two (81.5%) of Staphylococcus aureus iso-
lated from blood were resistant to cloxacillin. Table 4
shows antimicrobial resistance pattern of organisms iso-
lated form blood culture.
Of the isolated Klebsiella spp from swabs 97.4% (75/77)
were resistant to ampicillin and 88.7% (63/71) of Escheri-
chia coli isolates from swabs were resistant to ampicillin.
Gentamycin resistance from Klebsiella spp and Escheri-
chia coli were noted in 61% (47/77) and 39.4% (28/71)
respectively. Of the Staphylococcus aureus isolates from
swabs 80.3% (106/132) were resistant to cloxacillin
(Table 5).
Clinical features
Participants with fever 21.9% (66/302) and hypothermia
62.5% (5/8) were noted to have higher frequency of sep-
sis as compared to those with normal body temperature
15.0% (3/20), p=0.02. Occurrence of sepsis was also
noted to be higher among neonates who had skin rash
with pustules 16/31 (51.6%) as compared to those with-
out skin rashes 58/299 (19.4%),p<0.001 . Presence of
skin rashes with pustule was an independent predicator
of sepsis [OR 0.26, 95% CI (0.10-0.66), p=0.004].
Table 2 Bacterial isolation from blood
Organism Early and late infection (days) (N=74) Total N(%) p value
0 – 6 n(%) 7 – 28 n(%)
Staphylococcus aureus 15 (55.6) 12 (44.4) 27 (36.5) 0.721*
Klebsiella species 17 (77.3) 5 (22.7) 22 (29.7)
Escherichia coli 10 (71.4) 4 (28.6) 14 (18.9)
Staphylococcus epidermidis 6 (100) 0 (0) 6 (8.1)
Group B Streptococci 1 (100) 0 (0) 1 (1.4)
Pseudomonas spp 1 (50.0) 1 (50.0) 2 (2.7)
Other streptococcus species 2 (100) 0 (0) 2 (2.7)
Total 52 (70.3) 22 (29.7) 74 (100)
*Fisher’s exact test.
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Forty-six (13.9%) neonates recruited in this study died.
Thirty six neonates out of 253 (14.2%) aged between 0–6
and 10/77 (13%) aged between 7–28 days died. Neonates
with sepsis were noted to have significantly higher pro-
portion of deaths 18/74 (24.3%) as compared to those
without sepsis 28/256 (10.9%) p=0.003. No association
was noted between type of isolated bacteria and death
p=0.196 (Fisher’s exact test).
Discussion
From the findings of this study, neonatal sepsis is com-
mon and contributes significantly to mortality among
neonates admitted in the neonatal ward at Muhimbili
National Hospital. The prevalence of positive blood cul-
ture sepsis of 22.4% observed in this study is higher than
15.9% reported by Bloomberg et al. [10] from a study
conducted earlier at this hospital. It is also higher than
6.5% which was reported by Klingenberg et al. [6] from a
study conducted in another Tanzanian referral hospital.
The increase in prevalence of sepsis could be accounted
for by the increase in resistance to antimicrobial which
may have resulted in inadequate treatment in lower
health care facilities. Collectively, our study and that of
Bloomberg et al. [10] indicate a high magnitude of neo-
natal sepsis at MNH, which may reflect low quality ofTable 3 Bacterial isolation from pus swabs
Organism Early and late infection (d
0 – 6 n (%)
Staphylococcus aureus 98 (74.2)
Klebsiella species 61 (79.2)
Escherichia coli 57 (80.3)
Staphylococcus epidermidis 3 (100)
Pseudomonas species 6 (85.7)
Proteus species 7 (100)
Total 232(78.1)
*Fisher’s exact test.neonatal care as opposed to developed countries which
have lower prevalence rates of neonatal sepsis [7,14].
Clinical outcome of neonatal sepsis
In this study, the overall neonatal mortality was 13.9%
(46/330), being higher in neonates with sepsis (24%) as
compared to those without (10%). Reports from other
two referral hospitals in Tanzania by Kayange et al. [5]
and Klingenberg et al. [6] found infant mortality due to
neonatal sepsis to be 19% and matched closely with the
findings of 18% by Mugalu et al. in a Ugandan study
[15]. Collectively, these findings reflect the significant
contribution of neonatal sepsis in both neonatal and
infant mortality.
Aetiology of neonatal sepsis
We found Staphylococcus aureus, Klebsiella spp and
Escherichia coli to be the predominant bacterial isolates,
which is in keeping with findings from a number of
studies conducted in sub-Saharan Africa [5,16-19]. Kleb-
siella spp was the main isolate in early onset sepsis while
Staphylococcus aureus dominated in late onset sepsis
and this is similar to report by Mokuolu et al. in a study
which was conducted in Nigeria [17]. Organisms isolated
with respect to time of onset in this study seem to fit
with the proposed sources of bacteria in neonatal sepsisays) (N=297) Total n (%) p value
7 – 28 n (%)
34 (25.8) 132(44.4) 0.616*
16 (20.8) 77 (25.9)
14 (19.7) 71 (23.9)
0 (0) 3 (1.0)
1 (14.3) 7 (2.4)
0 (0) 7 (2.4)
65 (21.9) 297 (100)
Table 4 Antimicrobial resistance pattern of isolated bacteria from blood (N=74)
Organism Antibacterial agent
Amp R n (%) Clox R n (%) Gent R n (%) Amik R n (%) Cefur R n (%) Ceft R n(%)
Staphy. aureus 23 (85.2) 22 (81.5) 15 (55.6) 0 (0) 4 (14.8) 4 (14.8)
Klebsiella species 22 (100) 21 (95.5) 17 (77.3) 1 (4.5) 8 (36.4) 4 (18.2)
E. coli 13 (92.9) 14 (100) 6 (42.9) 0 (0) 1 (7.1) 2 (14.3)
Group B Streptococci 0 (0) 1 (100) 1 (100) 0 (0) 0 (0) 0 (0)
Pseudomonas spp 1 (50) 0 (0) 0 (0) 0 (0) 1 (50) 1 (50)
Other Strept. species 1 (50) 0 (0) 1 (50) 0 (0) 0 (0) 0 (0)
Total 60 (88.2) 58 (85.3) 40 (58.8) 1 (1.5) 14 (20.6) 11 (16.2)
Amp: Ampicillin, Clox: Cloxacillin, Gent: Gentamycin, Amik: Amikacin, Cefur: Cefuroxime, Ceft: Ceftriaxone, R: Resistance.
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spp was the predominant isolate, and hospital sources
or community for late sepsis in which Staphylococcus
aureus was predominant isolate, respectively [7,19].
Staphylococcus aureus was the main isolate from swabs
which may be attributed to acquisition of bacteria through
handling of the neonates by health care providers and
family members.Antimicrobial susceptibility of bacterial isolates
Our findings show that most of the bacterial isolates
showed high resistance to ampicillin, cloxacillin and gen-
tamycin which are first line antimicrobials for treating
neonatal sepsis at our centre. More than 80% of
Staphylococcus aureus and more than 90% of Klebsiella
spp from both blood and swabs were resistant to ampi-
cillin and cloxacillin, while more than 50% of Staphylo-
coccus aureus and more than 60% of Klebsiella spp were
resistant to gentamycin. High resistance noted may be
attributed to excessive and irrational use of these anti-
biotics at primary health facilities from which neonates
are referred to our centre.
Notably, the resistance of all isolates to ceftriaxone,
cefuroxime and amikacin was significantly low. At MNH
ceftriaxone is used a second line, while cefuroxime and
amikacin are not included in the protocol of neonatal
sepsis management. From our findings and other studies
in the region showing high levels of antimicrobialTable 5 Antimicrobial resistance pattern of isolated bacteria
Organism
Amp R n (%) Clox R n (%) Gent R
Staphy aureus 116 (87.9) 106 (80.3) 69 (52.3
Kleb species 75 (97.4) 75 (97.4) 47 (61)
E. coli 63 (88.7) 60 (84.5) 28 (39.4
Pseudomonas spp 7 (100) 7 (100) 4 (57.1)
Proteus species 6 (85.7) 5 (71.4) 2 (28.6)
Total 267(90.8) 253 (86.1) 150 (5
Amp: Ampicillin, Clox: Cloxacillin, Gent: Gentamycin, Amik: Amikacin, Cefur: Cefuroxresistance to ampicillin, cloxacillin and gentamycin
[6,18,20] it is apparent that the current antimicrobial
regiment for empirical treatment of neonatal sepsis need
to be revisited. Amikacin and cefuroxime may be alter-
native choice of antimicrobials in empiric treatment of
neonatal sepsis however these will be more expensive.
Study limitations
Some of the study participants referred to our hospital
might have been inadequately treated resulting in selec-
tion bias in our study. Anaerobes which may cause sep-
sis and other infections with similar presentation to
sepsis including malaria [21] were not looked for in this
study. Staphylococcus epidermidis isolated in early neo-
natal sepsis 6/52 (11.5%) may be due to contamination
during blood collection [22,23]. Extended beta lactamase
resistant strains were not determined and resistance to
methicillin by Staphylococcus aureus isolates were not
determined in this study.
Conclusions
Staphylococcus aureus and Klebsiella spp were the pre-
dominant bacterial isolates in this study and showed
high resistance to ampicillin and cloxacillin which are
WHO recommended and routinely used antimicrobial at
MNH. This calls for institutional based antimicrobial
surveillance to guide choices of antibiotics for treating
neonatal sepsis.from swabs (N=2974)
Antibacterial agent
n (%) Amik R n (%) Cefur R n (%) Ceft R n (%)
) 7 (5.3) 45 (34.1) 55 (41.7)
2 (2.6) 34 (44.2) 31 (40.3)
) 5 (7) 24 (33.8) 19 (26.8)
0 (0) 4 (57.1) 6 (85.7)
0 (0) 0 (0) 2 (28.6)
1.0) 14 (4.8) 107(36.4) 113 (38.4)
ime, Ceft: Ceftriaxone, R: Resistance.
Mhada et al. BMC Public Health 2012, 12:904 Page 6 of 6
http://www.biomedcentral.com/1471-2458/12/904Competing interests
Authors declare that they have no competing interests.
Authors’ contributions
TVM designed the study, collected data, analyzed data and participated in
manuscript preparation. FF assisted in data collection, analysis and prepared
the manuscript. MIM and AM critically reviewed the study protocol,
supervised data collection and participated in manuscript preparation. All
authors have read and approved the final manuscript.
Acknowledgements
Authors are grateful to the nurses in the neonatal ward of Muhimbili
National Hospital for facilitating data collection. Special thanks to laboratory
technicians in the Department of Microbiology and Immunology, MUHAS for
carrying out laboratory tests. Ministry of Health and Social Welfare of
Tanzania is acknowledged for funding this research work.
Author details
1Department of Paediatrics, Bugando Medical Centre, P O Box 1370, Mwanza,
Tanzania. 2Department of Paediatrics and Child Health, School of Medicine,
Muhimbili University of Health and Allied Sciences, P O Box 65001, Dar es
Salaam, Tanzania. 3Department of Microbiology and Immunology, School of
Medicine, Muhimbili University of Health and Allied Sciences, P O Box 65001,
Dar es Salaam, Tanzania.
Received: 30 May 2012 Accepted: 22 October 2012
Published: 24 October 2012
References
1. Lawn JE, Cousens S, Zupan J: 4 million neonatal deaths: when? where?
why? Lancet 2005, 365:891–900.
2. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT: Neonatal
sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed 2005,
90:220–24.
3. Seale AC, Mwaniki M, Newton CRJC, Berkley JA: Maternal and early onset
neonatal bacterial sepsis: burden and strategies for prevention in
sub-Saharan Africa. Lancet Infect Dis 2009, 9(7):428–438.
4. Shalini Tripathi S, Malik GK: Neonatal Sepsis: past, present and future; a
review article. Inter J Med Up 2010, 5(2):45–54.
5. Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE:
Predictors of positive blood culture and death among neonates with
suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania.
BMC Pediatr 2010, 10:39.
6. Klingenberg C, Olomi R, Oneko M, Sam N, Langeland N: Neonatal
morbidity and mortality in a Tanzanian tertiary care hospital. Ann Trop
Paediatr 2003, 23(4):293–9.
7. Edmund K, Zaidi A: New approaches to preventing, diagnosing and
treating neonatal sepsis. PLoS Med 2010, 7(3):e1000213.
8. Qazi AS, Stoll BJ: Neonatal sepsis- A major global public health challenge.
Ped Infect Dis J 2009, 28:1.
9. Bradford PA: Extended spectrum beta lactamases in the 21st
century-Characterization epidemiology and detection of this important
resistance threat. Clin Microbiol Rev 2001, 14:933–951.
10. Blomberg B, Manji KP, Urassa WK, et al: Antimicrobial resistance predicts
death in Tanzanian children with bloodstream infections: a prospective
cohort study. BMC Infect Dis 2007, 7:43.
11. WHO: Integrated Management of Childhood Illnesses Handbook. Geneva:
2005. http://whqlibdoc.who.int/publications/2005/9241546700.pdf. ISBN
92 4 154670 0 (NLM classification: WS 29).
12. Barrow GI, Feltham RKA: Cowan and Steel’s Manual for Identification of
Medical Bacteria. 3rd edition. Cambridge: Cambridge University Press; 2003.
13. Clinical and Laboratory Standard Institute: Performance standards for
antimicrobial disk susceptibility tests. Approved standard. In Ninth edition
document M2-A9. Wayne: Clinical and Laboratory Standards Institute; 2006.
14. World Health Organization: Essential Newborn Care. In A report of Technical
Working Group. Geneva: WHO; 1995. https://apps.who.int/rht/documents/
MSM96-13/essential_newborn_care.htm.
15. Mugalu J, Nakakeeto MK, Kiguli S, Kaddu-Mullindwa DH: Aetiology, risk
factors and immediate outcome of bacteriologically confirmed neonatal
septicaemia in Mulago hospital, Uganda. Afr Health Sci 2006, 6:120–126.16. Iregbu KC, Elegba OY, Babaniyi IB: Bacteriological profile of neonatal
septicemia in a tertiary hospital in Nigeria. Afr Health Sci 2006,
6(3):151–154.
17. Mokuolu AO, Jiya N, Adesiyun OO: Neonatal septicemia in Ilorin: bacteria
pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci 2002,
31:127–130.
18. Shitaye D, Asrat D, Woldeamanuel Y, Worku B: Risk factors and etiology of
neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia. Ethiop Med
J 2010, 48(1):11–21.
19. Newton O, English M: Young infant sepsis: aetiology, antibiotic
susceptibility and clinical signs. Trans R Soc Trop Med Hyg 2007,
101(10–4):959–966.
20. Musoke RN, Revathi G: Emergence of multidrug-resistance gram-negative
organisms in a neonatal unit and therapeutic implications. J Trop Pediatr
2000, 46(2):89–91.
21. Mwaniki MK, Talbert AW, Mturi FN, Berkeley JA, Kager P, Marsh K, Newton
CR: Congeital and neonatal malaria in a rural Kenyan district hospital:
An eight year analysis. Malaria J 2010, 9:313.
22. Hasemizadeh Z, Bazargani A, Davarpanah AM: Blood culture contamination
in a neonatal intensive care unit in Shiraz, Southwest-Central Iran. Med
Princ Pract 2011, 20:133–6.
23. Wolkowiez MC, Moran C, Benjamin DK, Cotton CM, Clark RH, Benjamin DK
Jr, Smith B: Early and late sepsis in late preterm infants. Paed Infect Dis J
2009, 28(12):1252–6.
doi:10.1186/1471-2458-12-904
Cite this article as: Mhada et al.: Neonatal sepsis at Muhimbili National
Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity
pattern and clinical outcome. BMC Public Health 2012 12:904.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
